RxDoctor Payments Data

Erin Himes, PA

Medical · Tollesboro, KYNPI 1043283252

Payments from drug & device makers

$1,097in general payments, 2019–2025

Across 53 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$603
  • Exact Sciences$113
  • Dexcom, Inc.$95
  • Pfizer$65
  • AstraZeneca$64
  • Lilly USA, LLC$32
  • plus $125 from 6 others

What the payments were for

  • Food & beverage$1,097100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,097 in reported general payments places this provider in the 55th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,592
Medicare patients
42
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide57$58,262
OzempicSemaglutide30$35,556
JanuviaSitagliptin Phosphate19$23,908
EliquisApixaban22$17,960
InvokanaCanagliflozin14$13,508
FarxigaDapagliflozin Propanediol18$13,380
Spiriva HandihalerTiotropium Bromide15$8,704
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$5,526
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,077
Albuterol Sulfate HfaAlbuterol Sulfate103$2,647
Ventolin HfaAlbuterol Sulfate20$1,439
Atorvastatin Calcium243$1,281
Pantoprazole Sodium150$954
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic16$947
Duloxetine Hcl62$874

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$32$58,26257 claims
Novo NordiskOzempic$19$35,55630 claims
MerckJanuvia$11$23,90819 claims
PfizerEliquis$65$17,96022 claims
AstraZenecaFarxiga$64$13,38018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 222 medical providers in Kentucky.

Other medical in Tollesboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →